ZIPRASIDONE

ZIPRASIDONE was reported 3603 times

ZIPRASIDONE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANOSOGNOSIA 101 0.1315
1 BLOOD PROLACTIN ABNORMAL 109 0.1263
2 ANTIPSYCHOTIC DRUG LEVEL BELOW THERAPEUTIC 78 0.1129
3 DECREASED EYE CONTACT 32 0.1053
4 PHARYNGEAL DYSTONIA 2 0.0909
5 SOMATOFORM DISORDER PREGNANCY 4 0.0870
6 WERNICKE-KORSAKOFF SYNDROME 5 0.0794
7 OPPOSITIONAL DEFIANT DISORDER 30 0.0759
8 CARDIOMETABOLIC SYNDROME 7 0.0737
9 PERSONALITY CHANGE DUE TO A GENERAL MEDICAL CONDITION 9 0.0720
10 SPASMODIC DYSPHONIA 20 0.0660
11 DISINHIBITION 81 0.0503
12 MALIGNANT CATATONIA 13 0.0494
13 PLASMA CELL MASTITIS 2 0.0417
14 DISTURBANCE IN SOCIAL BEHAVIOUR 97 0.0411
15 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 15 0.0373
16 POVERTY OF THOUGHT CONTENT 3 0.0366
17 ORTHOSTATIC HYPERTENSION 21 0.0360
18 CHOREOATHETOSIS 22 0.0324
19 SCHIZOAFFECTIVE DISORDER 52 0.0291
20 DELUSION OF REFERENCE 4 0.0288
21 HYPEROSMOLAR HYPERGLYCAEMIC STATE 4 0.0286
22 ANTICHOLINERGIC EFFECT 2 0.0267
23 GRANDIOSITY 9 0.0246
24 SOCIAL ANXIETY DISORDER 14 0.0213
25 MULTIPLE DRUG HYPERSENSITIVITY 2 0.0208
26 IDEAS OF REFERENCE 2 0.0196
27 DELUSION OF PARASITOSIS 3 0.0191
28 ATTENTION-SEEKING BEHAVIOUR 3 0.0191
29 THERAPEUTIC PRODUCT EFFECT VARIABLE 74 0.0191
30 ANTICONVULSANT DRUG LEVEL ABOVE THERAPEUTIC 12 0.0185
31 ELECTROCONVULSIVE THERAPY 2 0.0183
32 METABOLIC DISORDER 106 0.0182
33 HALLUCINATION, TACTILE 12 0.0180
34 DYSLIPIDAEMIA 90 0.0177
35 POSTURING 9 0.0173
36 PERSEVERATION 3 0.0161
37 METABOLIC SYNDROME 26 0.0158
38 HYPERBILIRUBINAEMIA NEONATAL 9 0.0155
39 RESPIRATORY MUSCLE WEAKNESS 5 0.0154
40 OCULOGYRIC CRISIS 33 0.0154
41 CATATONIA 80 0.0152
42 NEONATAL RESPIRATORY DEPRESSION 5 0.0151
43 BLUNTED AFFECT 11 0.0149
44 POLYDIPSIA PSYCHOGENIC 3 0.0146
45 FEMALE SEXUAL DYSFUNCTION 3 0.0132
46 MYOPATHY TOXIC 8 0.0129
47 NEUROLEPTIC MALIGNANT SYNDROME 146 0.0123
48 DYSDIADOCHOKINESIS 2 0.0117
49 AKATHISIA 157 0.0115
50 ATHETOSIS 2 0.0115
51 OBSESSIVE-COMPULSIVE DISORDER 90 0.0112
52 PERSECUTORY DELUSION 27 0.0108
53 ELECTROCARDIOGRAM QT CORRECTED INTERVAL PROLONGED 8 0.0102
54 SEXUAL DYSFUNCTION 117 0.0100
55 ELECTROCARDIOGRAM QT SHORTENED 3 0.0099
56 HYPERKINESIA 21 0.0099
57 PERSONALITY CHANGE 92 0.0099
58 SELECTIVE EATING DISORDER 9 0.0099
59 ANAL SQUAMOUS CELL CARCINOMA 3 0.0097
60 DELUSIONAL PERCEPTION 4 0.0096
61 SLEEP-RELATED EATING DISORDER 9 0.0096
62 TONGUE SPASM 3 0.0096
63 SCHIZOPHRENIA 115 0.0095
64 ECHOLALIA 3 0.0094
65 DYSMORPHISM 22 0.0093
66 COMPULSIONS 6 0.0090
67 MYOTONIA 2 0.0090
68 DROWNING 9 0.0089
69 ANTIPSYCHOTIC DRUG LEVEL INCREASED 25 0.0089
70 EUPHORIC MOOD 85 0.0083
71 BRADYPNOEA 22 0.0081
72 OBESITY 129 0.0081
73 INTESTINAL PSEUDO-OBSTRUCTION 7 0.0080
74 DISTRIBUTIVE SHOCK 18 0.0079
75 EXPOSURE VIA INGESTION 20 0.0079
76 MEAN ARTERIAL PRESSURE DECREASED 2 0.0079
77 HOMICIDAL IDEATION 32 0.0079
78 SEDATION COMPLICATION 20 0.0078
79 MUSCLE NECROSIS 7 0.0077
80 GRIMACING 6 0.0077
81 MASKED FACIES 3 0.0074
82 BLOOD PROLACTIN INCREASED 34 0.0072
83 JEALOUS DELUSION 2 0.0071
84 DYSTONIA 134 0.0069
85 OROMANDIBULAR DYSTONIA 5 0.0069
86 POSTURE ABNORMAL 22 0.0068
87 DELUSION OF GRANDEUR 3 0.0067
88 VENTRICULAR ARRHYTHMIA 24 0.0066
89 ABULIA 6 0.0065
90 STEREOTYPY 6 0.0064
91 SEDATION 166 0.0063
92 IMPULSE-CONTROL DISORDER 13 0.0063
93 BRUXISM 34 0.0063
94 PARKINSONISM 61 0.0063
95 PRESSURE OF SPEECH 4 0.0062
96 BOREDOM 2 0.0059
97 STASIS DERMATITIS 4 0.0058
98 ALVEOLITIS ALLERGIC 6 0.0058
99 HYPOTONIA NEONATAL 9 0.0058
100 SUSPICIOUSNESS 4 0.0057
101 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 5 0.0056
102 HERBAL INTERACTION 2 0.0055
103 VASOPLEGIA SYNDROME 9 0.0055
104 OBSESSIVE-COMPULSIVE SYMPTOM 2 0.0054
105 TRISMUS 28 0.0054
106 AGITATION NEONATAL 5 0.0052
107 BODY MASS INDEX INCREASED 7 0.0052
108 PROTRUSION TONGUE 3 0.0051
109 HAEMATOMA MUSCLE 6 0.0050
110 RADIUS FRACTURE 12 0.0050
111 PSYCHOMOTOR RETARDATION 14 0.0050
112 ALCOHOL ABUSE 13 0.0049
113 PSYCHOTIC SYMPTOM 10 0.0048
114 INCREASED APPETITE 88 0.0046
115 NITRITE URINE PRESENT 2 0.0046
116 DIVORCED 2 0.0045
117 ELECTROCARDIOGRAM ST-T SEGMENT ABNORMAL 2 0.0045
118 DYSKINESIA 177 0.0044
119 HYPERTENSIVE HEART DISEASE 8 0.0043
120 INTRUSIVE THOUGHTS 5 0.0042
121 TORTICOLLIS 9 0.0042
122 PATIENT UNCOOPERATIVE 2 0.0042
123 BLOOD BICARBONATE INCREASED 2 0.0042
124 HALLUCINATION, AUDITORY 66 0.0041
125 MUTISM 6 0.0041
126 PULMONARY ARTERY STENOSIS CONGENITAL 3 0.0041
127 NODAL RHYTHM 6 0.0041
128 COMPLETED SUICIDE 337 0.0040
129 LEUKAEMIA 38 0.0040
130 CLONUS 11 0.0040
131 GESTATIONAL DIABETES 19 0.0040
132 FALSE POSITIVE INVESTIGATION RESULT 4 0.0040
133 SUICIDE ATTEMPT 238 0.0039
134 POLYHYDRAMNIOS 4 0.0039
135 QRS AXIS ABNORMAL 3 0.0039
136 MICROCEPHALY 5 0.0039
137 SUSPECTED SUICIDE 18 0.0038
138 EXTRAPYRAMIDAL DISORDER 95 0.0038
139 FEELING GUILTY 5 0.0038
140 STREPTOCOCCAL INFECTION 21 0.0038
141 NEUROMYOPATHY 4 0.0038
142 BINGE EATING 4 0.0037
143 MARITAL PROBLEM 2 0.0037
144 PITUITARY TUMOUR BENIGN 6 0.0037
145 PRESCRIBED OVERDOSE 69 0.0036
146 DRUG EFFECT VARIABLE 4 0.0035
147 PRIAPISM 12 0.0035
148 HYPERAMMONAEMIC ENCEPHALOPATHY 6 0.0034
149 ADENOMYOSIS 2 0.0034
150 OVERWEIGHT 18 0.0033
151 GAMBLING DISORDER 9 0.0033
152 HALLUCINATIONS, MIXED 14 0.0033
153 PSYCHOTIC DISORDER 97 0.0033
154 CERUMEN IMPACTION 3 0.0033
155 ELECTROCARDIOGRAM T WAVE ABNORMAL 5 0.0032
156 INTUSSUSCEPTION 3 0.0031
157 RESPIRATORY DISORDER NEONATAL 5 0.0031
158 PSYCHIATRIC DECOMPENSATION 6 0.0031
159 ILLUSION 5 0.0030
160 MULTIPLE DRUG OVERDOSE 15 0.0030
161 HYPOSPADIAS 6 0.0029
162 NUTRITIONAL CONDITION ABNORMAL 2 0.0029
163 SEROTONIN SYNDROME 55 0.0029
164 FOETAL HEART RATE DECELERATION ABNORMALITY 2 0.0028
165 NEONATAL RESPIRATORY DISTRESS SYNDROME 10 0.0028
166 JARISCH-HERXHEIMER REACTION 2 0.0028
167 HYPERPROLACTINAEMIA 18 0.0028
168 OBSESSIVE THOUGHTS 5 0.0028
169 NONINFECTIVE GINGIVITIS 4 0.0028
170 DIABETES MELLITUS NON-INSULIN-DEPENDENT 4 0.0027
171 TIC 15 0.0027
172 DELUSION 42 0.0027
173 SALIVARY HYPERSECRETION 27 0.0027
174 TARDIVE DYSKINESIA 76 0.0027
175 HYPERTHERMIA MALIGNANT 4 0.0027
176 FACIAL SPASM 3 0.0027
177 PARANOIA 46 0.0027
178 GASTROINTESTINAL HYPOMOTILITY 6 0.0027
179 MULTIPLE DRUG THERAPY 2 0.0027
180 GALACTORRHOEA 17 0.0026
181 REBOUND ACID HYPERSECRETION 8 0.0026
182 THYROTOXIC CRISIS 3 0.0026
183 TROPONIN INCREASED 20 0.0026
184 MYOCARDITIS 30 0.0026
185 ELECTROCARDIOGRAM QT PROLONGED 94 0.0026
186 NEPHROGENIC DIABETES INSIPIDUS 3 0.0026
187 HYPERREFLEXIA 9 0.0026
188 PROCALCITONIN INCREASED 3 0.0026
189 DRUG LEVEL BELOW THERAPEUTIC 14 0.0025
190 INAPPROPRIATE AFFECT 4 0.0025
191 INTRACRANIAL PRESSURE INCREASED 14 0.0025
192 COORDINATION ABNORMAL 35 0.0025
193 AFFECT LABILITY 24 0.0025
194 KETONURIA 2 0.0025
195 ACUTE PSYCHOSIS 6 0.0024
196 AUTONOMIC NERVOUS SYSTEM IMBALANCE 7 0.0024
197 LEFT ATRIAL DILATATION 3 0.0024
198 PSYCHOMOTOR HYPERACTIVITY 39 0.0023
199 CHOREA 4 0.0023
200 EMBOLISM VENOUS 7 0.0023
201 HYPOTHERMIA 23 0.0023
202 MUSCLE RIGIDITY 27 0.0023
203 DISTURBANCE IN SEXUAL AROUSAL 2 0.0022
204 SHOCK 50 0.0022
205 BILIARY TRACT DISORDER 3 0.0022
206 PULSELESS ELECTRICAL ACTIVITY 9 0.0022
207 ORAL ADMINISTRATION COMPLICATION 2 0.0022
208 SOMNAMBULISM 14 0.0021
209 ELECTROCARDIOGRAM CHANGE 2 0.0021
210 AGGRESSION 105 0.0021
211 INTENTIONAL MISUSE 4 0.0021
212 PCO2 DECREASED 2 0.0021
213 JUDGEMENT IMPAIRED 3 0.0021
214 INSURANCE ISSUE 31 0.0020
215 SUBSTANCE ABUSE 16 0.0020
216 RESPIRATORY ARREST 54 0.0020
217 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
218 TORSADE DE POINTES 15 0.0019
219 PERSONALITY DISORDER 5 0.0019
220 PSYCHOMOTOR SKILLS IMPAIRED 5 0.0019
221 COGWHEEL RIGIDITY 2 0.0019
222 CEREBRAL DISORDER 14 0.0019
223 BONE DEMINERALISATION 2 0.0019
224 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
225 BLOOD SODIUM ABNORMAL 2 0.0019
226 AREFLEXIA 5 0.0019
227 TOXICITY TO VARIOUS AGENTS 315 0.0019
228 BREAST ENLARGEMENT 6 0.0018
229 INFECTION SUSCEPTIBILITY INCREASED 4 0.0018
230 SMALL FOR DATES BABY 9 0.0018
231 ELECTROCARDIOGRAM T WAVE INVERSION 4 0.0018
232 RHABDOMYOLYSIS 75 0.0018
233 ILEUS PARALYTIC 8 0.0018
234 POLYDIPSIA 7 0.0018
235 COMPUTERISED TOMOGRAM ABNORMAL 4 0.0018
236 MANIA 29 0.0018
237 LEUKOPENIA 88 0.0018
238 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 9 0.0018
239 BLOOD PH DECREASED 3 0.0018
240 CARDIO-RESPIRATORY ARREST 73 0.0017
241 DISTRACTIBILITY 2 0.0017
242 IRRITABILITY 104 0.0017
243 MORBID THOUGHTS 2 0.0017
244 MUSCLE CONTRACTIONS INVOLUNTARY 6 0.0017
245 GLUCOSE TOLERANCE IMPAIRED 10 0.0017
246 DRUG WITHDRAWAL CONVULSIONS 3 0.0017
247 MOOD ALTERED 46 0.0017
248 COMA 80 0.0017
249 SINUS BRADYCARDIA 16 0.0017
250 STARING 4 0.0017
251 SLOW SPEECH 4 0.0016
252 CONDUCTION DISORDER 3 0.0016
253 TEARFULNESS 7 0.0016
254 SUICIDAL IDEATION 147 0.0016
255 IMPULSIVE BEHAVIOUR 6 0.0016
256 MULTIPLE DRUG OVERDOSE INTENTIONAL 5 0.0016
257 GESTATIONAL HYPERTENSION 2 0.0015
258 TACHYPNOEA 21 0.0015
259 CUTANEOUS LUPUS ERYTHEMATOSUS 3 0.0015
260 POISONING 19 0.0015
261 PACKED RED BLOOD CELL TRANSFUSION 2 0.0015
262 ANION GAP INCREASED 2 0.0015
263 POTENTIATING DRUG INTERACTION 5 0.0015
264 COMPULSIVE SHOPPING 3 0.0015
265 TONGUE BITING 3 0.0015
266 VENOUS THROMBOSIS LIMB 3 0.0015
267 CULTURE URINE POSITIVE 2 0.0014
268 DEPRESSIVE SYMPTOM 5 0.0014
269 GLOMERULAR FILTRATION RATE ABNORMAL 2 0.0014
270 CATAPLEXY 2 0.0014
271 HYPERNATRAEMIA 7 0.0014
272 NEUROLOGICAL SYMPTOM 8 0.0014
273 DEREALISATION 3 0.0014
274 DYSPHORIA 7 0.0014
275 BIPOLAR DISORDER 15 0.0014
276 ORTHOSTATIC HYPOTENSION 24 0.0014
277 OLIGOMENORRHOEA 3 0.0014
278 BIPOLAR I DISORDER 3 0.0014
279 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 97 0.0014
280 AXILLARY PAIN 2 0.0013
281 CARDIAC DYSFUNCTION 5 0.0013
282 LARGE INTESTINAL HAEMORRHAGE 3 0.0013
283 HYPERCAPNIA 4 0.0013
284 HAEMODYNAMIC INSTABILITY 10 0.0013
285 COMMUNICATION DISORDER 5 0.0013
286 COGNITIVE DISORDER 61 0.0013
287 BLOOD CHOLESTEROL ABNORMAL 6 0.0013
288 MEAN CELL VOLUME DECREASED 2 0.0013
289 AFFECTIVE DISORDER 10 0.0013
290 SKIN ABRASION 6 0.0013
291 POOR QUALITY SLEEP 27 0.0013
292 SUPRAVENTRICULAR TACHYCARDIA 12 0.0013
293 LONG QT SYNDROME 3 0.0013
294 EXPOSURE TO TOXIC AGENT 4 0.0012
295 METABOLIC ALKALOSIS 2 0.0012
296 ENURESIS 5 0.0012
297 BRONCHITIS CHRONIC 3 0.0012
298 VENTRICULAR TACHYCARDIA 20 0.0012
299 DRUG LEVEL INCREASED 20 0.0012
300 MENTAL STATUS CHANGES 33 0.0012
301 HALLUCINATION, VISUAL 25 0.0012
302 HOSTILITY 3 0.0012
303 DROOLING 8 0.0012
304 CRYING 42 0.0012
305 DELIRIUM 40 0.0012
306 PRODUCT PRESCRIBING ISSUE 25 0.0011
307 DRUG INTERACTION 182 0.0011
308 BLOOD CREATINE PHOSPHOKINASE INCREASED 33 0.0011
309 BLOOD LACTIC ACID INCREASED 6 0.0011
310 DRUG SCREEN NEGATIVE 2 0.0011
311 LOGORRHOEA 4 0.0011
312 SPEECH DISORDER 58 0.0011
313 BLOOD PRESSURE SYSTOLIC DECREASED 5 0.0011
314 WEIGHT INCREASED 246 0.0011
315 HYPERSEXUALITY 2 0.0011
316 MEAN CELL HAEMOGLOBIN DECREASED 2 0.0011
317 NEPHROGENIC ANAEMIA 5 0.0011
318 ACCIDENTAL DEATH 2 0.0011
319 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
320 BRADYPHRENIA 7 0.0011
321 CARDIAC ARREST 88 0.0011
322 HEPATIC NECROSIS 4 0.0011
323 INTENTIONAL OVERDOSE 68 0.0011
324 RESTLESSNESS 38 0.0010
325 SKIN WARM 6 0.0010
326 ABORTION 3 0.0010
327 HYPERTRIGLYCERIDAEMIA 6 0.0010
328 BLOOD TRIGLYCERIDES INCREASED 18 0.0010
329 RESPIRATORY ACIDOSIS 4 0.0010
330 BRADYKINESIA 6 0.0010
331 CARDIOMYOPATHY 15 0.0010
332 TYPE 2 DIABETES MELLITUS 34 0.0010
333 AGITATION 74 0.0010
334 CEREBRAL ATROPHY 4 0.0010
335 SYMPTOM RECURRENCE 6 0.0010
336 DEVELOPMENTAL DELAY 9 0.0010
337 LOSS OF EMPLOYMENT 3 0.0010
338 TENSION 6 0.0010
339 SELF INJURIOUS BEHAVIOUR 3 0.0010
340 RESPIRATORY DEPRESSION 12 0.0010
341 CHRONIC KIDNEY DISEASE 73 0.0010
342 ABNORMAL BEHAVIOUR 38 0.0010
343 SELF-INJURIOUS IDEATION 4 0.0010
344 HYPERPYREXIA 4 0.0009
345 BUNDLE BRANCH BLOCK LEFT 4 0.0009
346 STUPOR 3 0.0009
347 MYOPATHY 8 0.0009
348 HYPOVENTILATION 3 0.0009
349 DYSPHEMIA 4 0.0009
350 SUSPECTED COVID-19 3 0.0009
351 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 3 0.0009
352 WHEELCHAIR USER 4 0.0009
353 BRAIN INJURY 9 0.0009
354 BACTERIAL TEST POSITIVE 2 0.0009
355 APHASIA 27 0.0009
356 B-CELL LYMPHOMA 3 0.0009
357 INFARCTION 6 0.0009
358 EYE MOVEMENT DISORDER 6 0.0009
359 GYNAECOMASTIA 27 0.0009
360 DENGUE FEVER 2 0.0009
361 TACHYPHRENIA 3 0.0009
362 FLAT AFFECT 2 0.0009
363 POLYURIA 7 0.0009
364 TUBULOINTERSTITIAL NEPHRITIS 16 0.0009
365 EMBOLIC STROKE 3 0.0009
366 DEPRESSED MOOD 45 0.0009
367 MENTAL DISORDER 37 0.0008
368 TACHYCARDIA 75 0.0008
369 FOOT FRACTURE 16 0.0008
370 OXYGEN CONSUMPTION INCREASED 2 0.0008
371 HYPERCHOLESTEROLAEMIA 8 0.0008
372 ADVERSE DRUG REACTION 74 0.0008
373 END STAGE RENAL DISEASE 15 0.0008
374 DIABETIC NEUROPATHY 4 0.0008
375 BLEPHAROSPASM 5 0.0008
376 SNORING 3 0.0008
377 INTENTIONAL SELF-INJURY 16 0.0008
378 BRADYCARDIA 42 0.0008
379 GENERALISED TONIC-CLONIC SEIZURE 13 0.0008
380 DIABETIC COMPLICATION 2 0.0008
381 MOTOR DYSFUNCTION 8 0.0008
382 INITIAL INSOMNIA 8 0.0008
383 MYDRIASIS 10 0.0008
384 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 8 0.0008
385 CACHEXIA 4 0.0008
386 THERAPEUTIC PRODUCT INEFFECTIVE 3 0.0008
387 INCOHERENT 5 0.0008
388 LIPOMA 2 0.0008
389 SLEEP DISORDER 54 0.0008
390 ANHEDONIA 20 0.0008
391 BLOOD ALBUMIN DECREASED 6 0.0008
392 HYPERPHAGIA 3 0.0008
393 POST-TRAUMATIC STRESS DISORDER 5 0.0007
394 MENTAL IMPAIRMENT 18 0.0007
395 NORMAL NEWBORN 4 0.0007
396 DEMYELINATION 3 0.0007
397 JAW DISORDER 4 0.0007
398 SELF-MEDICATION 3 0.0007
399 DRUG SCREEN FALSE POSITIVE 2 0.0007
400 PNEUMONIA ASPIRATION 18 0.0007
401 HALLUCINATION 54 0.0007
402 TREATMENT NONCOMPLIANCE 39 0.0007
403 ATTENTION DEFICIT HYPERACTIVITY DISORDER 3 0.0007
404 ACUTE KIDNEY INJURY 109 0.0007
405 OXYGEN SATURATION ABNORMAL 2 0.0007
406 SINUS TACHYCARDIA 10 0.0007
407 LEFT VENTRICULAR HYPERTROPHY 3 0.0007
408 AGRANULOCYTOSIS 13 0.0007
409 BACTERIAL INFECTION 13 0.0007
410 ATRIOVENTRICULAR BLOCK FIRST DEGREE 3 0.0007
411 ELECTROLYTE IMBALANCE 8 0.0007
412 GASTROINTESTINAL NECROSIS 2 0.0007
413 NECK INJURY 2 0.0007
414 ANGER 23 0.0007
415 HYPERCHLORHYDRIA 4 0.0007
416 HYPERLIPIDAEMIA 8 0.0007
417 DIABETES MELLITUS 50 0.0007
418 DRUG LEVEL ABOVE THERAPEUTIC 3 0.0007
419 ACIDOSIS 5 0.0007
420 WHITE BLOOD CELL COUNT INCREASED 25 0.0007
421 DIASTOLIC DYSFUNCTION 2 0.0006
422 BRAIN DEATH 2 0.0006
423 LETHARGY 37 0.0006
424 PRODUCT ADMINISTRATION INTERRUPTED 5 0.0006
425 DISORIENTATION 25 0.0006
426 BLADDER PAIN 2 0.0006
427 DIABETIC KETOACIDOSIS 15 0.0006
428 DRUG RESISTANCE 16 0.0006
429 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 16 0.0006
430 UNRESPONSIVE TO STIMULI 16 0.0006
431 DYSARTHRIA 23 0.0006
432 DEAFNESS NEUROSENSORY 2 0.0006
433 LISTLESS 2 0.0006
434 BLOOD GLUCOSE INCREASED 114 0.0006
435 ADVERSE REACTION 8 0.0006
436 HYPERAMMONAEMIA 3 0.0006
437 URINARY RETENTION 20 0.0006
438 DEPRESSION 136 0.0006
439 HAEMODIALYSIS 5 0.0006
440 THINKING ABNORMAL 11 0.0006
441 ATAXIA 7 0.0006
442 MYOCLONUS 7 0.0006
443 DIFFICULTY IN WALKING 2 0.0006
444 EJECTION FRACTION DECREASED 9 0.0006
445 MICTURITION DISORDER 2 0.0006
446 THERAPY PARTIAL RESPONDER 9 0.0006
447 INCONTINENCE 6 0.0006
448 TREMOR 94 0.0006
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 5 0.0006
450 FACIAL PARESIS 2 0.0006
451 FIBRIN D DIMER INCREASED 2 0.0006
452 SENSORY DISTURBANCE 9 0.0006
453 DECREASED ACTIVITY 6 0.0006
454 ANAL INCONTINENCE 5 0.0006
455 BEHAVIOUR DISORDER 3 0.0006
456 FOETAL EXPOSURE DURING PREGNANCY 45 0.0006
457 TONGUE DISORDER 4 0.0006
458 LIVER TRANSPLANT 2 0.0005
459 RESTLESS LEGS SYNDROME 10 0.0005
460 APATHY 8 0.0005
461 MAJOR DEPRESSION 4 0.0005
462 SWOLLEN TONGUE 17 0.0005
463 PRODUCT ADMINISTRATION ERROR 11 0.0005
464 HYPOMANIA 2 0.0005
465 PARADOXICAL DRUG REACTION 2 0.0005
466 TREATMENT FAILURE 45 0.0005
467 CONDITION AGGRAVATED 165 0.0005
468 ALCOHOL USE 2 0.0005
469 GRAND MAL CONVULSION 5 0.0005
470 SOMNOLENCE 109 0.0005
471 ANXIETY 154 0.0005
472 BODY TEMPERATURE INCREASED 11 0.0005
473 RENAL INJURY 16 0.0005
474 DISTURBANCE IN ATTENTION 29 0.0005
475 POISONING DELIBERATE 5 0.0005
476 GRANULOCYTOPENIA 3 0.0005
477 HYPERTHERMIA 4 0.0005
478 GASTRIC INFECTION 2 0.0005
479 MATERNAL DRUGS AFFECTING FOETUS 4 0.0005
480 SOCIAL AVOIDANT BEHAVIOUR 3 0.0005
481 LOW DENSITY LIPOPROTEIN INCREASED 4 0.0005
482 HYPOXIA 18 0.0005
483 DECREASED INTEREST 3 0.0005
484 ENERGY INCREASED 3 0.0005
485 LIGAMENT SPRAIN 5 0.0005
486 PREMATURE BABY 15 0.0005
487 LEUKOCYTOSIS 9 0.0005
488 C-REACTIVE PROTEIN INCREASED 18 0.0005
489 OVERDOSE 106 0.0005
490 ASPARTATE AMINOTRANSFERASE INCREASED 26 0.0005
491 HYPERTENSION 103 0.0005
492 DISEASE RECURRENCE 23 0.0005
493 ILEUS 6 0.0005
494 HYPOTENSION 96 0.0005
495 NERVOUSNESS 25 0.0005
496 INTENTIONAL DRUG MISUSE 10 0.0005
497 GLYCOSYLATED HAEMOGLOBIN INCREASED 12 0.0005
498 URINARY INCONTINENCE 14 0.0005
499 ALANINE AMINOTRANSFERASE INCREASED 29 0.0005
500 SCREAMING 3 0.0005
501 HYPOPHAGIA 12 0.0005
502 INSOMNIA 125 0.0005
503 FACIAL PARALYSIS 4 0.0005
504 BREAST PAIN 5 0.0005
505 HEPATIC PAIN 2 0.0005
506 ACUTE RESPIRATORY FAILURE 9 0.0005
507 THERAPY NON-RESPONDER 21 0.0005
508 EXPOSURE DURING PREGNANCY 29 0.0005
509 ABNORMAL SENSATION IN EYE 2 0.0005
510 PRODUCT USE IN UNAPPROVED INDICATION 115 0.0005
511 ECONOMIC PROBLEM 7 0.0005
512 URINE OUTPUT DECREASED 4 0.0005
513 DEPRESSED LEVEL OF CONSCIOUSNESS 18 0.0005
514 GASTROINTESTINAL PAIN 5 0.0005
515 SEIZURE 52 0.0004
516 VERTIGO 27 0.0004
517 LUPUS-LIKE SYNDROME 4 0.0004
518 IMPAIRED GASTRIC EMPTYING 6 0.0004
519 METABOLIC ACIDOSIS 14 0.0004
520 PRODUCT SUBSTITUTION ISSUE 25 0.0004
521 SUBDURAL HAEMATOMA 6 0.0004
522 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 23 0.0004
523 RENAL FAILURE 55 0.0004
524 HYPERGLYCAEMIA 15 0.0004
525 FEAR 11 0.0004
526 CONFUSIONAL STATE 66 0.0004
527 ENCEPHALOPATHY 10 0.0004
528 THERAPY CHANGE 4 0.0004
529 SMALL INTESTINAL OBSTRUCTION 5 0.0004
530 DRUG INEFFECTIVE 534 0.0004
531 MOVEMENT DISORDER 13 0.0004
532 HYPERVOLAEMIA 2 0.0004
533 RASH MACULO-PAPULAR 9 0.0004
534 AMENORRHOEA 7 0.0004
535 TOXIC SKIN ERUPTION 4 0.0004
536 CONTRAINDICATED PRODUCT ADMINISTERED 12 0.0004
537 HYPERHIDROSIS 51 0.0004
538 EYE DISORDER 13 0.0004
539 AMMONIA INCREASED 2 0.0004
540 BOWEL MOVEMENT IRREGULARITY 3 0.0004
541 PETIT MAL EPILEPSY 2 0.0004
542 TEMPERATURE INTOLERANCE 4 0.0004
543 ANKLE FRACTURE 6 0.0004
544 NICOTINE DEPENDENCE 3 0.0004
545 HYPERSOMNIA 11 0.0004
546 WITHDRAWAL SYNDROME 16 0.0004
547 BEDRIDDEN 5 0.0004
548 NYSTAGMUS 2 0.0004
549 DYSSTASIA 11 0.0004
550 BLOOD DISORDER 3 0.0004
551 GASTROINTESTINAL MOTILITY DISORDER 2 0.0004
552 THERAPEUTIC RESPONSE DECREASED 22 0.0004
553 MENSTRUAL DISORDER 3 0.0004
554 DENTAL CARIES 4 0.0004
555 EOSINOPHIL COUNT INCREASED 3 0.0004
556 TRANSAMINASES INCREASED 8 0.0004
557 PANIC ATTACK 13 0.0004
558 REBOUND EFFECT 4 0.0004
559 HYPERTONIA 2 0.0003
560 PSYCHOLOGICAL TRAUMA 3 0.0003
561 MOOD SWINGS 11 0.0003
562 HYPERVENTILATION 2 0.0003
563 HYPOKINESIA 5 0.0003
564 SPINAL OSTEOARTHRITIS 3 0.0003
565 SEPSIS 38 0.0003
566 DRUG WITHDRAWAL SYNDROME NEONATAL 5 0.0003
567 RENAL FAILURE ACUTE 14 0.0003
568 NOCTURIA 4 0.0003
569 EATING DISORDER 7 0.0003
570 DRUG ABUSER 2 0.0003
571 IRON DEFICIENCY ANAEMIA 3 0.0003
572 EMOTIONAL DISORDER 10 0.0003
573 HEPATIC STEATOSIS 6 0.0003
574 NEPHROPATHY 3 0.0003
575 NERVOUS SYSTEM DISORDER 10 0.0003
576 BLOOD SODIUM DECREASED 6 0.0003
577 ERECTILE DYSFUNCTION 8 0.0003
578 CARDIAC FLUTTER 2 0.0003
579 DRY MOUTH 25 0.0003
580 PHARYNGEAL SWELLING 3 0.0003
581 HEPATOMEGALY 3 0.0003
582 DYSGRAPHIA 2 0.0003
583 ACTIVITIES OF DAILY LIVING IMPAIRED 6 0.0003
584 RESPIRATORY FAILURE 22 0.0003
585 BLOOD CHOLESTEROL INCREASED 14 0.0003
586 VISION BLURRED 41 0.0003
587 QUALITY OF LIFE DECREASED 4 0.0003
588 DRUG LEVEL DECREASED 3 0.0003
589 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
590 NEUTROPHIL COUNT INCREASED 3 0.0003
591 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 14 0.0003
592 TENDERNESS 3 0.0003
593 HYPERTRANSAMINASAEMIA 2 0.0003
594 HYPOMAGNESAEMIA 4 0.0003
595 PAPULE 2 0.0003
596 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
597 DIABETES MELLITUS INADEQUATE CONTROL 5 0.0003
598 HAND FRACTURE 2 0.0003
599 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
600 CARDIOGENIC SHOCK 4 0.0003
601 SKIN LACERATION 3 0.0003
602 INTENTIONAL PRODUCT MISUSE 24 0.0003
603 ASPIRATION 3 0.0003
604 BLINDNESS TRANSIENT 2 0.0003
605 BLOOD PRESSURE DIASTOLIC DECREASED 2 0.0003
606 HYPOPHOSPHATAEMIA 2 0.0003
607 VENTRICULAR FIBRILLATION 3 0.0003
608 FEELING DRUNK 2 0.0003
609 MALNUTRITION 3 0.0003
610 MIDDLE INSOMNIA 5 0.0003
611 FALL 88 0.0003
612 MICTURITION URGENCY 3 0.0003
613 BLOOD CREATININE INCREASED 17 0.0003
614 PHARYNGEAL OEDEMA 4 0.0003
615 THROAT TIGHTNESS 7 0.0003
616 APNOEA 2 0.0003
617 SPINAL PAIN 3 0.0003
618 PRODUCT USE ISSUE 48 0.0003
619 GASTROINTESTINAL INFLAMMATION 2 0.0003
620 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
621 RESPIRATORY DISTRESS 7 0.0003
622 DRUG SCREEN POSITIVE 2 0.0003
623 LOW BIRTH WEIGHT BABY 2 0.0003
624 GINGIVAL PAIN 2 0.0003
625 WRIST FRACTURE 3 0.0003
626 MIOSIS 2 0.0002
627 ATRIAL FIBRILLATION 24 0.0002
628 DEEP VEIN THROMBOSIS 16 0.0002
629 NO THERAPEUTIC RESPONSE 3 0.0002
630 DYSURIA 9 0.0002
631 HYPERAESTHESIA 2 0.0002
632 BALANCE DISORDER 21 0.0002
633 ABNORMAL WEIGHT GAIN 3 0.0002
634 HAIR DISORDER 2 0.0002
635 GENERALISED OEDEMA 3 0.0002
636 DYSPHAGIA 23 0.0002
637 BLOOD ALKALINE PHOSPHATASE INCREASED 6 0.0002
638 HAIR COLOUR CHANGES 3 0.0002
639 VISUAL ACUITY REDUCED 8 0.0002
640 SYNCOPE 24 0.0002
641 MUSCULOSKELETAL STIFFNESS 21 0.0002
642 LIVE BIRTH 2 0.0002
643 CONSTIPATION 52 0.0002
644 DRUG USE DISORDER 2 0.0002
645 JOINT INJURY 5 0.0002
646 IMPAIRED WORK ABILITY 5 0.0002
647 MULTI-ORGAN FAILURE 4 0.0002
648 HYPONATRAEMIA 13 0.0002
649 FACIAL PAIN 2 0.0002
650 THIRST 4 0.0002
651 GASTROENTERITIS VIRAL 4 0.0002
652 HEAD INJURY 7 0.0002
653 PULMONARY EMBOLISM 21 0.0002
654 OFF LABEL USE 193 0.0002
655 DRUG TOXICITY 3 0.0002
656 PELVIC PAIN 4 0.0002
657 OSTEOPOROSIS 9 0.0002
658 PERIPHERAL COLDNESS 3 0.0002
659 PNEUMONIA BACTERIAL 2 0.0002
660 BRAIN NEOPLASM 2 0.0002
661 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
662 MUSCLE TWITCHING 5 0.0002
663 HYPOKALAEMIA 10 0.0002
664 DRUG ABUSE 18 0.0002
665 LACTIC ACIDOSIS 7 0.0002
666 HUNGER 3 0.0002
667 APHONIA 3 0.0002
668 HYPOCALCAEMIA 4 0.0002
669 FRACTURE 4 0.0002
670 MUSCULAR WEAKNESS 24 0.0002
671 MEMORY IMPAIRMENT 29 0.0002
672 BLOOD URINE PRESENT 4 0.0002
673 DEHYDRATION 28 0.0002
674 PARALYSIS 3 0.0002
675 IMPAIRED QUALITY OF LIFE 3 0.0002
676 BLOOD PRESSURE FLUCTUATION 5 0.0002
677 LIVER FUNCTION TEST ABNORMAL 6 0.0002
678 OEDEMA PERIPHERAL 25 0.0002
679 COELIAC DISEASE 2 0.0002
680 BODY TEMPERATURE DECREASED 2 0.0002
681 WHITE BLOOD CELL COUNT DECREASED 22 0.0002
682 ABASIA 5 0.0002
683 NIGHTMARE 7 0.0002
684 HAEMATOCRIT DECREASED 4 0.0002
685 RASH MACULAR 7 0.0002
686 PRODUCT QUALITY ISSUE 27 0.0002
687 GAIT DISTURBANCE 38 0.0002
688 EMOTIONAL DISTRESS 24 0.0002
689 DECREASED APPETITE 46 0.0002
690 MEDICATION ERROR 11 0.0002
691 OSTEOPENIA 3 0.0002
692 EPILEPSY 6 0.0002
693 URINARY TRACT INFECTION 33 0.0002
694 DRUG EFFECT INCOMPLETE 7 0.0002
695 POLLAKIURIA 8 0.0002
696 PETECHIAE 2 0.0002
697 NEUTROPENIA 26 0.0002
698 PANCREATITIS 10 0.0002
699 IRRITABLE BOWEL SYNDROME 4 0.0002
700 LIVER FUNCTION TEST INCREASED 4 0.0002
701 ALTERED STATE OF CONSCIOUSNESS 4 0.0002
702 BACK DISORDER 3 0.0002
703 BACK INJURY 2 0.0002
704 PRODUCT DOSE OMISSION 12 0.0002
705 MULTIPLE FRACTURES 3 0.0002
706 BLOOD GLUCOSE FLUCTUATION 2 0.0002
707 DRUG WITHDRAWAL SYNDROME 16 0.0002
708 FEBRILE NEUTROPENIA 12 0.0002
709 PLEURAL EFFUSION 11 0.0002
710 TOOTH DISORDER 4 0.0002
711 HEPATOTOXICITY 4 0.0002
712 FEELING COLD 5 0.0002
713 MATERNAL EXPOSURE DURING PREGNANCY 16 0.0002
714 PANCREATITIS ACUTE 4 0.0002
715 HEMIPARESIS 3 0.0002
716 PNEUMONIA 57 0.0002
717 CAESAREAN SECTION 2 0.0002
718 EOSINOPHILIA 3 0.0002
719 INJURY 12 0.0002
720 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 5 0.0002
721 ACUTE RESPIRATORY DISTRESS SYNDROME 3 0.0002
722 FATIGUE 132 0.0002
723 PRODUCT PRESCRIBING ERROR 4 0.0002
724 ACCIDENT 2 0.0002
725 RESPIRATORY DISORDER 5 0.0002
726 HEPATIC FAILURE 5 0.0002
727 HEPATITIS C 2 0.0002
728 MUSCLE SPASMS 30 0.0002
729 MUSCLE SPASTICITY 2 0.0002
730 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
731 CARDIOMEGALY 2 0.0002
732 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
733 EYE SWELLING 6 0.0002
734 CYST 2 0.0002
735 NECK PAIN 9 0.0002
736 PHOTOPHOBIA 3 0.0002
737 DERMATITIS ALLERGIC 2 0.0002
738 SLEEP APNOEA SYNDROME 3 0.0002
739 CYSTITIS 5 0.0002
740 CHEST PAIN 29 0.0002
741 DIZZINESS 78 0.0002
742 LOWER LIMB FRACTURE 3 0.0002
743 LOSS OF CONSCIOUSNESS 20 0.0002
744 HAEMATOMA 4 0.0002
745 INJECTION SITE INDURATION 2 0.0002
746 PALPITATIONS 18 0.0002
747 RESPIRATORY TRACT INFECTION 4 0.0002
748 CHILLS 18 0.0002
749 NEPHROLITHIASIS 7 0.0002
750 ORAL CANDIDIASIS 2 0.0002
751 HAIR TEXTURE ABNORMAL 2 0.0001
752 PERIPHERAL SWELLING 23 0.0001
753 RASH PRURITIC 8 0.0001
754 LIMB INJURY 4 0.0001
755 RASH ERYTHEMATOUS 7 0.0001
756 DRUG INTOLERANCE 14 0.0001
757 ORAL DISCOMFORT 2 0.0001
758 ASTHENIA 54 0.0001
759 CARPAL TUNNEL SYNDROME 2 0.0001
760 HEART RATE DECREASED 5 0.0001
761 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
762 ADVERSE EVENT 13 0.0001
763 HEPATOCELLULAR INJURY 2 0.0001
764 DIALYSIS 2 0.0001
765 HYPERTHYROIDISM 2 0.0001
766 FEELING ABNORMAL 33 0.0001
767 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
768 CHEST DISCOMFORT 14 0.0001
769 THERAPY CESSATION 7 0.0001
770 WEIGHT DECREASED 38 0.0001
771 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
772 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
773 HEPATIC FUNCTION ABNORMAL 5 0.0001
774 SNEEZING 3 0.0001
775 BONE LOSS 2 0.0001
776 HYPOAESTHESIA ORAL 2 0.0001
777 LACRIMATION INCREASED 4 0.0001
778 DYSPEPSIA 13 0.0001
779 PRODUCT AVAILABILITY ISSUE 3 0.0001
780 DRUG DISPENSING ERROR 2 0.0001
781 VOMITING 61 0.0001
782 LIMB DISCOMFORT 4 0.0001
783 MUSCULOSKELETAL CHEST PAIN 2 0.0001
784 CYANOSIS 2 0.0001
785 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 9 0.0001
786 ARTHROPATHY 7 0.0001
787 INTENTIONAL PRODUCT USE ISSUE 11 0.0001
788 ABSCESS 2 0.0001
789 OXYGEN SATURATION DECREASED 7 0.0001
790 CARDIAC FAILURE CONGESTIVE 10 0.0001
791 HIP FRACTURE 4 0.0001
792 EYE PAIN 7 0.0001
793 MUSCLE TIGHTNESS 2 0.0001
794 BLOOD POTASSIUM INCREASED 2 0.0001
795 AMNESIA 8 0.0001
796 PSORIASIS 16 0.0001
797 LIVER INJURY 3 0.0001
798 CHOLELITHIASIS 4 0.0001
799 HEART RATE INCREASED 12 0.0001
800 MALAISE 53 0.0001
801 COAGULOPATHY 2 0.0001
802 SKIN DISORDER 4 0.0001
803 ROAD TRAFFIC ACCIDENT 5 0.0001
804 BLOOD UREA INCREASED 2 0.0001
805 PERICARDITIS 2 0.0001
806 HAEMATEMESIS 3 0.0001
807 CARDIOVASCULAR DISORDER 3 0.0001
808 FLUID RETENTION 6 0.0001
809 HEPATITIS 3 0.0001
810 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
811 MIGRAINE 11 0.0001
812 ILL-DEFINED DISORDER 7 0.0001
813 VAGINAL HAEMORRHAGE 5 0.0001
814 DYSPNOEA 65 0.0001
815 DISCOMFORT 7 0.0001
816 FEELING HOT 7 0.0001
817 ANGIOEDEMA 5 0.0001
818 HEAD DISCOMFORT 2 0.0001
819 DRUG ERUPTION 2 0.0001
820 ISCHAEMIC STROKE 2 0.0001
821 MENSTRUATION IRREGULAR 3 0.0001
822 BACK PAIN 26 0.0001
823 THROMBOSIS 9 0.0001
824 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
825 GOUT 2 0.0001
826 THERAPEUTIC RESPONSE UNEXPECTED 5 0.0001
827 DRUG EFFECT DECREASED 6 0.0001
828 BLOOD PRESSURE INCREASED 17 0.0001
829 BLOOD BILIRUBIN INCREASED 3 0.0001
830 OEDEMA 6 0.0001
831 WRONG TECHNIQUE IN DRUG USAGE PROCESS 4 0.0001
832 BONE DISORDER 2 0.0001
833 SKIN LESION 3 0.0001
834 INFLUENZA LIKE ILLNESS 9 0.0001
835 ABNORMAL DREAMS 3 0.0001
836 RHINORRHOEA 7 0.0001
837 COVID-19 19 0.0001
838 UPPER RESPIRATORY TRACT INFECTION 5 0.0001
839 FLUSHING 11 0.0001
840 RASH 47 0.0001
841 CONJUNCTIVITIS 2 0.0001
842 DEMENTIA 3 0.0001
843 INTESTINAL OBSTRUCTION 4 0.0001
844 PRODUCT DOSE OMISSION IN ERROR 3 0.0001
845 RED BLOOD CELL COUNT DECREASED 3 0.0001
846 BLOOD GLUCOSE DECREASED 5 0.0001
847 GLAUCOMA 2 0.0001
848 HERNIA 2 0.0001
849 EAR PAIN 2 0.0001
850 PAIN 63 0.0001
851 BLOOD PRESSURE SYSTOLIC INCREASED 2 0.0001
852 CHOKING 2 0.0001
853 HYPERSENSITIVITY 19 0.0001
854 NAUSEA 81 0.0001
855 NASAL CONGESTION 6 0.0001
856 HEADACHE 64 0.0001
857 MENORRHAGIA 2 0.0001
858 CATARACT 6 0.0001
859 HYPOAESTHESIA 15 0.0001
860 ABORTION SPONTANEOUS 4 0.0001
861 FULL BLOOD COUNT DECREASED 2 0.0001
862 CELLULITIS 5 0.0001
863 ABDOMINAL PAIN 23 0.0001
864 PYREXIA 34 0.0001
865 NEUTROPHIL COUNT DECREASED 4 0.0001
866 THERAPY INTERRUPTED 7 0.0001
867 OROPHARYNGEAL PAIN 9 0.0001
868 ABDOMINAL PAIN UPPER 20 0.0001
869 BONE DENSITY DECREASED 3 0.0001
870 MUSCULOSKELETAL PAIN 5 0.0001
871 RENAL IMPAIRMENT 8 0.0001
872 MYALGIA 16 0.0001
873 HYPOTHYROIDISM 3 0.0001
874 CONTUSION 9 0.0001
875 COUGH 26 0.0001
876 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
877 CLOSTRIDIUM DIFFICILE INFECTION 2 0.0001
878 HOSPITALISATION 14 0.0001
879 DEATH 78 0.0001
880 EXPIRED PRODUCT ADMINISTERED 3 0.0001
881 VIRAL INFECTION 3 0.0001
882 GAIT INABILITY 3 0.0001
883 GASTROINTESTINAL DISORDER 8 0.0001
884 THROAT IRRITATION 4 0.0001
885 ANAEMIA 17 0.0001
886 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 18 0.0001
887 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 3 0.0001
888 DIARRHOEA 57 0.0001
889 HEPATIC ENZYME INCREASED 6 0.0001
890 HAEMOGLOBIN DECREASED 9 0.0001
891 MULTIPLE SCLEROSIS RELAPSE 6 0.0001
892 DYSPHONIA 5 0.0001
893 SURGERY 5 0.0001
894 CEREBRAL HAEMORRHAGE 3 0.0001
895 MULTIPLE SCLEROSIS 4 0.0001
896 FIBROMYALGIA 2 0.0001
897 CEREBRAL INFARCTION 2 0.0001
898 ALOPECIA 16 0.0001
899 BRONCHITIS 6 0.0001
900 INFLUENZA 9 0.0001
901 THROMBOCYTOPENIA 9 0.0001
902 HOT FLUSH 6 0.0001
903 ABDOMINAL PAIN LOWER 2 0.0001
904 ERYTHEMA 16 0.0001
905 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
906 INFLAMMATION 4 0.0001
907 DIPLOPIA 2 0.0001
908 CEREBROVASCULAR ACCIDENT 13 0.0001
909 PARAESTHESIA 12 0.0001
910 DERMATITIS ATOPIC 4 0.0001
911 BLOOD PRESSURE DECREASED 5 0.0001
912 PLATELET COUNT DECREASED 8 0.0001
913 CARDIAC DISORDER 7 0.0001
914 PRODUCT DOSE OMISSION ISSUE 22 0.0001
915 SWELLING 7 0.0001
916 CARDIAC FAILURE 6 0.0001
917 PAIN IN EXTREMITY 22 0.0001
918 JAUNDICE 2 0.0001
919 FREQUENT BOWEL MOVEMENTS 2 0.0001
920 NEUROPATHY PERIPHERAL 7 0.0001
921 PALLOR 2 0.0001
922 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
923 DRUG DOSE OMISSION 12 0.0001
924 HAEMATOCHEZIA 4 0.0001
925 HAEMOPTYSIS 2 0.0001
926 DEVICE MALFUNCTION 5 0.0001
927 OSTEOARTHRITIS 3 0.0001
928 PAIN IN JAW 2 0.0001
929 INTENTIONAL DOSE OMISSION 2 0.0001
930 INTERNATIONAL NORMALISED RATIO INCREASED 2 0.0001
931 INCORRECT DOSE ADMINISTERED 16 0.0001
932 CONVULSION 4 0.0001
933 MOBILITY DECREASED 5 0.0001
934 SEPTIC SHOCK 3 0.0001
935 SINUSITIS 7 0.0001
936 BONE PAIN 4 0.0001
937 ARTHRALGIA 28 0.0001
938 ABDOMINAL DISTENSION 7 0.0001
939 HAEMORRHAGE 7 0.0001
940 JOINT SWELLING 8 0.0001
941 CORONARY ARTERY DISEASE 2 0.0001
942 TINNITUS 3 0.0001
943 ARRHYTHMIA 3 0.0001
944 INJECTION SITE BRUISING 5 0.0001
945 NIGHT SWEATS 2 0.0001
946 GENERAL PHYSICAL HEALTH DETERIORATION 7 0.0001
947 FUNGAL INFECTION 2 0.0001
948 GASTROINTESTINAL HAEMORRHAGE 5 0.0001
949 ABDOMINAL DISCOMFORT 10 0.0001
950 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 3 0.0001
951 ECZEMA 3 0.0001
952 DRUG DEPENDENCE 9 0.0001
953 INCORRECT ROUTE OF DRUG ADMINISTRATION 2 0.0001
954 INJECTION SITE PAIN 17 0.0001
955 INFECTION 8 0.0001
956 NO ADVERSE EVENT 10 0.0001
957 UNDERDOSE 4 0.0001
958 ACCIDENTAL OVERDOSE 2 0.0001
959 PRURITUS 21 0.0001
960 INJECTION SITE MASS 2 0.0001
961 ASTHMA 6 0.0001
962 STOMATITIS 3 0.0000
963 ILLNESS 5 0.0000
964 HYPOACUSIS 2 0.0000
965 INJECTION SITE PRURITUS 3 0.0000
966 COLITIS ULCERATIVE 2 0.0000
967 BURNING SENSATION 3 0.0000
968 DISEASE PROGRESSION 5 0.0000
969 SKIN BURNING SENSATION 3 0.0000
970 URTICARIA 7 0.0000
971 HYPOGLYCAEMIA 2 0.0000
972 LUNG DISORDER 2 0.0000
973 EPISTAXIS 3 0.0000
974 ARTHRITIS 3 0.0000
975 NASOPHARYNGITIS 7 0.0000
976 SKIN EXFOLIATION 3 0.0000
977 HERPES ZOSTER 2 0.0000
978 PRODUCT STORAGE ERROR 3 0.0000
979 VISUAL IMPAIRMENT 4 0.0000
980 INFUSION RELATED REACTION 2 0.0000
981 NEOPLASM MALIGNANT 2 0.0000
982 ACCIDENTAL EXPOSURE TO PRODUCT 3 0.0000
983 INJECTION SITE REACTION 2 0.0000
984 RHEUMATOID ARTHRITIS 3 0.0000
985 ACNE 2 0.0000
986 DRUG DOSE OMISSION BY DEVICE 2 0.0000
987 INJECTION SITE HAEMORRHAGE 2 0.0000
988 MYOCARDIAL INFARCTION 4 0.0000
989 DEVICE ISSUE 2 0.0000
990 DRY SKIN 2 0.0000